- Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Hepatology Research : the Official Journal of the Japan Society of Hepatology (2014)
Hori T, Uemoto S, Walden LB, et al.